预计2026年2月17日结束,OKYO Pharma筹集了2 000万美元,用于资助研发活动。 OKYO Pharma raised $20 million in a share offering to fund research and development, expected to close Feb. 17, 2026.

根据公司公告, OKYO Pharma已公开售出普通股份, 募集2,000万美元。 OKYO Pharma has priced a public offering of ordinary shares raising $20 million, according to a company announcement. 这项提议旨在支持该公司正在进行的研究、开发和商业化努力。 The offering is intended to support the company’s ongoing research, development, and commercialization efforts. 公告中未披露股票和每股价格的确切数目。 The exact number of shares and price per share were not disclosed in the announcement. 预计将在2026年2月17日或该日前后关闭。 The offering is expected to close on or about February 17, 2026.